These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 27624582)

  • 21. Adjuvant chemotherapy and prognostic factors in stage II colon cancer--Izmir Oncology Group Study.
    Kucukzeybek Y; Dirican A; Demir L; Yildirim S; Akyol M; Yildiz Y; Bayoglu IV; Alacacioglu A; Varol U; Salman T; Yildiz I; Can H; Tarhan MO
    Asian Pac J Cancer Prev; 2015; 16(6):2413-8. PubMed ID: 25824774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
    Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A
    Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
    Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
    Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
    Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study.
    Artac M; Turhal NS; Kocer M; Karabulut B; Bozcuk H; Yalcin S; Karaagac M; Gündüz S; Isik N; Uygun K
    Tumori; 2014; 100(2):143-8. PubMed ID: 24852857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer.
    Huh JW; Lee JH; Kim HR; Kim YJ
    Am J Surg; 2013 Nov; 206(5):758-63. PubMed ID: 23835209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
    An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
    World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer.
    Chang W; Wei Y; Ren L; Zhong Y; Yu Y; Chen J; Zhu D; Ye L; Qin C; Zhao N; Niu W; Qin X; Xu J
    Ann Surg; 2016 Mar; 263(3):434-9. PubMed ID: 26465781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype.
    De Franco L; Marrelli D; Voglino C; Vindigni C; Ferrara F; Di Mare G; Iudici L; Marini M; Roviello F
    Pathol Oncol Res; 2018 Apr; 24(2):393-400. PubMed ID: 28555306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in sporadic colon cancer with high-level microsatellite instability.
    Oh BY; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    Surgery; 2016 May; 159(5):1372-81. PubMed ID: 26775578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel histologic grading system based on lymphovascular invasion, perineural invasion, and tumor budding in colorectal cancer.
    Huh JW; Lee WY; Shin JK; Park YA; Cho YB; Kim HC; Yun SH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):471-477. PubMed ID: 30603899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evidence of perineural invasion on early-stage cervical cancer and prognostic significance].
    Zhang G; Yang Y; Zhu Y; Cui L; Jia S; Shi Y; Song S; Xu S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):673-8. PubMed ID: 26675394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of perineural invasion in patients with colorectal cancer.
    Hu G; Li L; Hu K
    Medicine (Baltimore); 2020 Apr; 99(17):e19860. PubMed ID: 32332645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
    Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
    Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience.
    Kim CA; Spratlin JL; Armstrong DE; Ghosh S; Mulder KE
    Clin Colorectal Cancer; 2014 Sep; 13(3):199-206. PubMed ID: 25088184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.